HHS Communications Regarding FDA Decision on Convalescent Plasma
Records from the U.S. Department of Health and Human Services in response to American Oversight's request for FDA communications regarding Covid-19 treatments. These records include communication concerning the FDA's decision to on convalescent plasma from August 2020.
Records from the U.S. Department of Health and Human Services in response to American Oversight’s request for FDA communications regarding Covid-19 treatments. These records include communication concerning the FDA’s decision to on convalescent plasma from August 2020.